Table 1 Baseline characteristics of the study population according to group (placebo or treatment)
Placebo group | Treatment group | |
|---|---|---|
Age (years) | 33.5 (±9.46) | 33.82 (±11.48) |
Sex | ||
Female | 55 | 47 |
Male | 18 | 26 |
Height (m) | 1.64 (±0.08) | 1.67 (±0.11) |
BMI (kg/m2) | 25.28 (±4.29) | 26.95 (±6.03) |
Mean symptom score | 14.23 (±4.09) | 14.89 (±3.78) |
Weight (kg) | 68.21 (±13.18) | 75.27 (±18.53) |
Time from symptom onset to start of treatment (h) | 42.29 (±17.54) | 46.57 (±15.65) |